Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
KRYS
KRYS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KRYS News
Krystal Biotech to Announce Q4 Earnings on February 17
2d ago
seekingalpha
Netflix Highlights a Rare Disease While Pearl Jam's Lead Singer Raises Funds for a Cure.
1d ago
Barron's
Soleus Capital Increases Stake in Celcuity
2d ago
Fool
Krystal Biotech Receives FDA RMAT Designation for KB707
6d ago
seekingalpha
Krystal Biotech Receives FDA RMAT Designation for KB707
6d ago
Newsfilter
Krystal Biotech Rated as One of the Top Growth Stocks for the Next Decade
Feb 04 2026
Yahoo Finance
Analysis of FBT Stock's 52-Week High and Low Points
Jan 27 2026
NASDAQ.COM
ImmunityBio (IBRX) Shares Surge 39.8% on Positive QUILT-106 Study Data
Jan 19 2026
NASDAQ.COM
S&P 500 Futures Decline in Pre-Market Trading; Tempus AI and Klarna Group Take the Lead
Jan 12 2026
Barron's
Krystal Biotech Projects $389M Revenue for VYJUVEK in 2025
Jan 12 2026
NASDAQ.COM
Krystal Biotech Reports $107M VYJUVEK Revenue for Q4 2025
Jan 11 2026
Globenewswire
Krystal Biotech (KRYS) Sees Options Trading Volume Surge to 2,445 Contracts
Jan 09 2026
NASDAQ.COM
Krystal Biotech (KRYS) Stock Rises 32.2%, Indicating Strong Trend
Jan 09 2026
NASDAQ.COM
Krystal Biotech to Release Interim Clinical Update on KB407 from Highest Dose Cohort of CORAL-1 Study
Jan 08 2026
NASDAQ.COM
Krystal Biotech to Present at 44th Annual J.P. Morgan Healthcare Conference
Jan 05 2026
Globenewswire
S&P 500 Futures Steady in Premarket Session; Regencell Bioscience and AngloGold Ashanti Take the Lead
Dec 30 2025
Barron's
Show More News
